TELEHEALTH ALLOWS FOR CLINICAL TRIAL PARTICIPATION AND MULTIMODALITY THERAPY IN A RURAL PATIENT WITH STAGE 4 NON-SMALL CELL LUNG CANCER.
TELEHEALTH ALLOWS FOR CLINICAL TRIAL PARTICIPATION AND MULTIMODALITY THERAPY IN A RURAL PATIENT WITH STAGE 4 NON-SMALL CELL LUNG CANCER.
复制标题
DOI：
10.1016/j.ctarc.2016.09.005
复制
发表时间：
2016-01-01
影响因子：
--
通讯作者：
David, Elizabeth A
中科院分区：
文献类型：
--
作者：
Clark, James M;Heifetz, Laurence J;David, Elizabeth A
农村地区少转移性非小细胞肺癌（NSCLC）患者采用传统治疗方法预后较差。多模式全身治疗结合手术切除可显著提高总生存率，导致临床完全缓解。目前接受的低转移性非小细胞肺癌的切除指征包括脑和肾上腺转移。众所周知，农村人口在治疗复杂恶性肿瘤方面存在差异，使用远程保健已被证明可以改善结果。我们报告了一例农村IV期非小细胞肺癌患者，他能够参加两个临床试验，接受三段式治疗，并保持无病18个月，其护理是通过三级医疗中心的远程医疗视频会议促进的。
Oligometastatic non-small cell lung cancer (NSCLC) has a poor prognosis for rural patients with traditional therapies. Implementation of multi-modality systemic therapy in conjunction with surgical resection can dramatically improve overall survival, leading to clinical complete remission. The currently accepted indications for resection in oligometastatic NSCLC include brain and adrenal metastases. Rural populations are known to have disparities in care of complex malignancies and the use of telehealth has been shown to improve outcomes. We present a case of a rural patient with stage IV NSCLC, who was able to participate in two clinical trials, undergo trimodality therapy, and remain disease-free for 18 months, whose care was facilitated via telehealth video conferencing with a tertiary care center.